glp-1 cancer risk Both Receptor Agonists and Bariatric Surgery Lower the of Weight-Related in Patients With Obesity GLP-1RA and thyroid cancer: New

J Perioper Pract

GLP-1 has been the incretin prioritised in drug discovery programs for T2DM

In a clinical trial, people receiving the treatment are able to adhere to the prescribed regimen through support from study staff and incentives for participation, whereas in a real-world setting people may experience side effects or lose insurance coverage and stop taking their medications, Stokes says

For example, once weekly dosing of tirzepatide (a dual GIPR and GLP-1R co-agonist) has superior efficacy for weight reduction compared to the GLP-1R agonist, semaglutide

GLP-1 pills are for adults aiming to lose weight or to improve their blood sugar regulation and management